Pentothal is one of 84 small molecule programs targeting Alcohol Dependence. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
52 competitors in Alcohol Dependence
Revia
Minipress
Antabuse
Depacon
Topamax
Selincro
Campral
Zoloft
Vimpat
Celexa
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Regulatory
Jan 1, 1982
PENTOTHAL
NDA NDA011679
Sources